# Evotec SE: financial statements, quarterly

EVO · Nasdaq · CIK 1412558 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evo.md) · [Financials](/companies/evo/financials.md) · [Filings](/companies/evo/filings.md) · [Insiders](/companies/evo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/evo/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [109](/filings/0001104659-22-049929.md) | [277](/filings/0001104659-23-059900.md) | [423](/filings/0001104659-24-089121.md) | [699](/filings/0001104659-25-035638.md) | [415](/filings/0001104659-25-035638.md) | [511](/filings/0001104659-25-035638.md) | [306](/filings/0001104659-25-035638.md) |
| Current assets | $m | not reported | not reported | [659](/filings/0001104659-22-049929.md) | [1,101](/filings/0001104659-23-059900.md) | [1,074](/filings/0001104659-24-089121.md) | [903](/filings/0001104659-25-035638.md) | [682](/filings/0001104659-25-035638.md) |
| Total assets | $m | not reported | not reported | [1,462](/filings/0001104659-22-049929.md) | [2,235](/filings/0001104659-23-059900.md) | [2,257](/filings/0001104659-24-089121.md) | [2,252](/filings/0001104659-25-035638.md) | [1,913](/filings/0001104659-25-035638.md) |
| Current liabilities | $m | not reported | not reported | [208](/filings/0001104659-22-049929.md) | [325](/filings/0001104659-23-059900.md) | [338](/filings/0001104659-24-089121.md) | [465](/filings/0001104659-25-035638.md) | [345](/filings/0001104659-25-035638.md) |
| Shareholders' equity | $m | [426](/filings/0001104659-22-049929.md) | [479](/filings/0001104659-23-059900.md) | [724](/filings/0001104659-22-049929.md) | [1,378](/filings/0001104659-23-059900.md) | [1,187](/filings/0001104659-24-089121.md) | [1,120](/filings/0001104659-25-035638.md) | [953](/filings/0001104659-25-035638.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 177,778,907 at 2025-12-31, from the cover of the [20-F filed 2026-04-08](/filings/0001104659-26-040767.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.